Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Veronica Hernström, et al. on LinkedIn:
“Largest AI Mammography Trial: Game-Changer!
- 105,934 women screened.
- 29% more cancers detected.
- 44% reduction in screen-reading workload.
- No rise in false positives.
AI is reshaping breast cancer screening!”
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.
Authors: Veronica Hernström, et al.
